Mengxia Chen
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Preoperative magnetic resonance imaging pelvic and prostatic parameters predict long-term urinary continence after Retzius-sparing robot-assisted radical prostatectomy.
Journal: Scientific reports
Published: December 07, 2024
The Value of 68Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI: A Prospective Single-Center Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 24, 2023
The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy.
Journal: Urologic oncology
Published: August 24, 2023
The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 02, 2023
Small ankyrin 1 (sANK1) promotes docetaxel resistance in castration-resistant prostate cancer cells by enhancing oxidative phosphorylation.
Journal: FEBS open bio
Published: July 08, 2022
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3.
Journal: Biomarker research
Published: April 19, 2022
Copper stress in grapevine: Consequences, responses, and a novel mitigation strategy using 5-aminolevulinic acid.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: January 26, 2022
Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative 68Ga-PSMA-11 PET/CT.
Journal: Frontiers in oncology
Published: July 22, 2021
Multi-omics analyses on the response mechanisms of 'Shine Muscat' grapevine to low degree of excess copper stress (Low-ECS).
Journal: Environmental pollution (Barking, Essex : 1987)
Published: February 08, 2021
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
Journal: The FEBS journal
Published: December 08, 2020
Last Updated: 09/26/2026